Consistent with an antitumor role of claudin-18 in lung cancer, loss of claudin-18 has been reported to activate YAP, resulting in increased abundance and proliferation of known distal lung progenitors, alveolar epithelial type II (AT2) cells, and tumorigenesis in mice (27). This evidence concerns the gene CLDN18 and lung carcinoma.